2006
DOI: 10.1016/j.currproblcancer.2006.04.001
|View full text |Cite
|
Sign up to set email alerts
|

Hodgkin’s Lymphoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
6
0

Year Published

2007
2007
2023
2023

Publication Types

Select...
4
3
1

Relationship

1
7

Authors

Journals

citations
Cited by 13 publications
(6 citation statements)
references
References 144 publications
(239 reference statements)
0
6
0
Order By: Relevance
“…Firstly, HD tissues contain variable numbers of reactive lymphocytes and macrophages. These lymphocytes are often of an activated, Th1 phenotype 1,2 . Secondly, these activated lymphocytes could contribute, by means of IL‐2 and IFN‐γ production, to the local activation of macrophages coexpressing TNF‐α, and some matrix metalloproteinases (MMP‐2 and MMP‐9) 12 .…”
Section: Reportmentioning
confidence: 99%
See 2 more Smart Citations
“…Firstly, HD tissues contain variable numbers of reactive lymphocytes and macrophages. These lymphocytes are often of an activated, Th1 phenotype 1,2 . Secondly, these activated lymphocytes could contribute, by means of IL‐2 and IFN‐γ production, to the local activation of macrophages coexpressing TNF‐α, and some matrix metalloproteinases (MMP‐2 and MMP‐9) 12 .…”
Section: Reportmentioning
confidence: 99%
“…Hodgkin's disease (HD) is a neoplasm of Hodgkin–Reed–Sternberg cells, arguably from B‐cell lineage, with variable numbers of reactive or inflammatory lymphocytes, macrophages and other cell populations 1 . These reactive cells are believed to be essential in the pathogenesis of the disease, probably through cytokine secretion 2 .…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…LRCHL is distinguished from NLPHL by the presence of scattered mononuclear cells and Reed–Sternberg cells. The Reed–Sternberg cells have a characteristic CD20−, CD45−, CD79−, CD15+, CD30+ immunophenotype as opposed to the large lymphohistiocytic (L&H) cells that predominate in NLPHL 12,14,15 . The L&H cells found in NLPHL have a delicate, multilobed nucleus resembling a popped popcorn kernel and are CD20+, CD45+, CD79+, CD15−, and C30− 12,14,15 …”
Section: Discussionmentioning
confidence: 99%
“…One feature of many adjuvant cancer treatments is that most patients do not actually benefit from them: the majority would have been cured without adjuvant therapy, or relapse in spite of receiving it. This is the case for adjuvant RT following doxorubicin-based chemotherapy for HL, which reduces the risk of relapse by approximately 7-20% depending on stage, disease bulk, intensity of chemotherapy, and other clinical features [3]. Several recently completed or ongoing clinical trials have been undertaken with the goal of improving the therapeutic ratio of HL treatment by more judiciously selecting patients for RT, and by reducing the radiation dose and volume among patients receiving it.…”
mentioning
confidence: 99%